文献速递脑血管病

卒中后神经修复治疗:临床试验设计原则

Neural Repair Therapies After Stroke: II. Principles for Clinical Trials
RSS 订阅 · Stroke

本文综述了卒中后神经修复治疗临床试验的设计原则,涵盖患者选择、对照组设计、干预时机、结局指标选择、经验依赖性可塑性、生物标志物使用及统计学考量。这些原则源自对关键卒中恢复试验的回顾,旨在优化旨在促进神经修复和改善功能的试验设计。

要点

  • 患者选择可结合神经影像和神经生理生物标志物以确保治疗靶点可行性。
  • 修复性试验中,模态特异性结局指标优于全局残疾量表。
  • 干预时机关键,需考虑卒中后生物学演变和可塑性关键期。

核心结论

  • 考虑这些关键原则有望改善旨在促进神经修复和改善卒中后功能的试验设计。
  • 研究者和临床医生在设计和解读临床试验时应关注这些因素,以最大化神经修复治疗改善卒中后残疾的可能性。

研究设计与样本

  • 本文为综述,回顾了关键卒中恢复试验,讨论了患者选择、对照组设计、干预时机、结局指标选择、经验依赖性可塑性、生物标志物使用及统计学考量等原则。

主要发现

  • 患者选择策略可能受益于结合神经影像和神经生理生物标志物以确保治疗靶点的可行性。
  • 模态特异性结局指标在修复性试验中优于全局残疾量表。
  • 干预时机至关重要,因为卒中后生物学不断演变且存在可塑性关键期。
  • 修复性治疗受益于与足够强度和适当类型的伴随经验配对,以塑造和强化脑回路。

临床怎么用

  • 研究者和临床医生在设计和解读临床试验时应关注患者选择、对照组设计、干预时机、结局指标、经验依赖性可塑性、生物标志物和统计学考量等原则。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Ahead of Print. Stroke remains a leading cause of human disability worldwide. Additional approaches beyond acute stroke therapies are needed to improve patient outcomes. Neural repair therapies focus on promoting neural plasticity in surviving tissue rather than modifying the acute injury; examples include behavioral training, drugs, biological therapies, and neural stimulation. This review discusses principles related to patient selection, control group design, intervention timing, choice of outcome measures, experience-dependent plasticity, use of biomarkers, and statistical considerations, each of which emerges from a review of key stroke recovery trials. Patient selection strategies may benefit from incorporating neuroimaging and neurophysiology biomarkers to ensure viability of treatment targets. Modality-specific outcome measures offer advantages over global disability scales for repair-based trials. The timing of intervention is critical given evolving poststroke biology and the existence of critical periods for plasticity. Repair-based therapies benefit from pairing with concomitant experience of sufficient intensity and appropriate type to shape and reinforce brain circuits. Consideration of these key principles is expected to improve the design of trials that aim to promote neural repair and improve function after stroke. Researchers and clinicians should attend to these factors when designing and interpreting clinical trials to maximize the likelihood that neural repair therapies will improve disability after stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Neural Repair Therapies After Stroke: II. Principles for Clinical Trials

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。